Hear from three leading Australian specialists as they discuss their views and insights around the use of biosimilar medicines
This activity will take approximately one hour to complete. Upon completion of this activity, participants will be able to:
Outline the clinical development and regulatory processes required prior to approval of biosimilar medicines
Explain how biosimilar medicines contribute to the sustainability of the Australian healthcare system
Outline clinical trial data which relate to switching/multiple switching between reference biological medicines and biosimilar brands.
Upon completion of this activity, you may claim one Category 1 credit as part of your MyCPD record.
Accreditation number: 231585